» Articles » PMID: 39732987

Exhaled Breath Metabolites Reveal Postmenopausal Gut-bone Cross-talk and Non-invasive Markers for Osteoporosis

Abstract

Background: Menopause driven decline in estrogen exposes women to risk of osteoporosis. Detection of early onset and silent progression are keys to prevent fractures and associated burdens.

Methods: In a discovery cohort of 120 postmenopausal women, we combined repeated quantitative pulse-echo ultrasonography of bone, assessment of grip strength and serum bone markers with mass-spectrometric analysis of exhaled metabolites to find breath volatile markers and quantitative cutoff levels for osteoporosis. Obtained markers and cutoffs were validated in an independent cohort of 49 age-matched women with six months apart seasonal follow-ups.

Results: Here, within the discovery cohort, concentrations of exhaled end-tidal dimethyl sulfide (DMS), allyl-methyl sulfide, butanethiol and butyric acid are increased (p ≤ 0.005) pronouncedly in subjects with bone mineral density (BMD) at high-risk of osteoporosis and fracture, when compared to subjects with normal BMD. Increased age and decreased grip strength are concomitant. All changes are reproduced during independent validation and seasonal follow-ups. Exhaled metabolite expressions remain age independent. Serum markers show random expressions without reproducibility. DMS exhalations differs between patients with recent, old and without fractures. Metabolite exhalations and BMDs are down-regulated during winter. ROC analysis in discovery cohort yields high classification accuracy of DMS with a cutoff for osteoporosis, which predicts subjects at high-risk within the independent validation cohort with >91% sensitivity and specificity.

Conclusions: Non-invasive analysis of exhaled DMS allowed more reliable classification of osteoporosis risk than conventional serum markers. We identified associations of exhaled organosulfur and short-chain fatty acids to bone metabolism in postmenopausal osteoporosis via a gut-bone axis.

References
1.
Navik U, Sheth V, Khurana A, Jawalekar S, Allawadhi P, Gaddam R . Methionine as a double-edged sword in health and disease: Current perspective and future challenges. Ageing Res Rev. 2021; 72:101500. DOI: 10.1016/j.arr.2021.101500. View

2.
Doyon A, Fischer D, Bayazit A, Canpolat N, Duzova A, Sozeri B . Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease. PLoS One. 2015; 10(2):e0113482. PMC: 4319910. DOI: 10.1371/journal.pone.0113482. View

3.
Sukul P, Trefz P, Kamysek S, Schubert J, Miekisch W . Instant effects of changing body positions on compositions of exhaled breath. J Breath Res. 2015; 9(4):047105. DOI: 10.1088/1752-7155/9/4/047105. View

4.
Shah S, Bell R, Davis S . Homocysteine, estrogen and cognitive decline. Climacteric. 2006; 9(2):77-87. DOI: 10.1080/13697130600641282. View

5.
Gaikwad N . Mass spectrometry evidence for formation of estrogen-homocysteine conjugates: estrogens can regulate homocysteine levels. Free Radic Biol Med. 2013; 65:1447-1454. DOI: 10.1016/j.freeradbiomed.2013.07.041. View